Posts filtered by tags: BioNtech[x]


 

BioNTech's Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn

Pioneered by a Turkish-German couple, its significance exceeds its practical valueThe world took note when the German startup BioNTech announced its breakthrough in the development of a new type of vaccine to combat Covid-19. After testing tens of thousands of people, BioNTech’s vaccine has been shown to be 95% effective in providing protection for those who would otherwise have been infected. The company was the first to apply for emergency use authorisation for a coronavirus vaccine in the US ...
Tags: Health, Europe, Business, Science, Biology, Germany, US, Society, US news, Genetics, Medical Research, Infectious Diseases, Microbiology, Pharmaceuticals industry, Vaccines and immunisation, Pfizer


Trump says coronavirus vaccine deliveries will start next week

The comments come ahead of a Dec. 10 meeting where FDA regulators will review Pfizer and BioNTech's request for an emergency use...
Tags: Fda, Pfizer, Trump, BioNtech


Moderna's groundbreaking coronavirus vaccine was designed in just 2 days

Moderna; Samantha Lee/Business Insider Moderna's coronavirus vaccine candidate is 94.5% effective at protecting people against COVID-19, according to the company. The candidate took under a year to develop and test, which is years faster than previous vaccines. The company designed its vaccine candidate in just two days. In contrast, traditional vaccines can take years to design. Visit Business Insider's homepage for more stories. Moderna's coronavirus vaccine candidate was found to be 94...
Tags: China, Trends, Atlantic, New York Times, Astrazeneca, Graham, Fda, Pfizer, Anthony Fauci, Nih, American Lung Association, Rizzo, The Food and Drug Administration, Seattle Washington, Novavax, Wuhan China


A 3rd coronavirus vaccine works

Hollis Johnson/Business Insider Hello,Another Monday, another batch of vaccine results. This time: AstraZeneca and the University of Oxford shared that their coronavirus vaccine was 70% effective on average. That comes on the heels of Pfizer and its partner BioNTech and Moderna both sharing last week that their coronavirus vaccines were 95% and 94.5% effective, respectively. Moncef Slaoui, the scientific head of Operation Warp Speed, is anticipating things will move quickly from here. He s...
Tags: Science, Massachusetts, US, Trends, Atlantic, Healthcare, Argentina, Astrazeneca, National Institutes of Health, Fda, Pfizer, Vaccine, University of Oxford, Oxford University, Santa, Donald Trump


Veteran investor Jeremy Grantham discussed the dot-com bubble, green investing, and America's poor handling of the pandemic in a recent interview. Here are the 10 best quotes

Morningstar / YouTube British investor Jeremy Grantham reflected on the dot-com bubble, trumpeted green investments, and criticized Americans' response to the pandemic in a RealVision interview released on Monday.The chief investment strategist of asset-manager GMO also praised Pfizer's partner BioNTech and Moderna for developing extremely effective COVID-19 vaccines in record time.Scroll down to read his 10 best quotes from the interview.Visit Business Insider's homepage for more stori...
Tags: Congress, US, America, Trends, Gmo, Warren Buffett, Pfizer, Goldman, Grantham, Morningstar, Alan Greenspan, Jeremy Grantham, Grantham Mayo van Otterloo, Moderna, BioNtech, General Electrics


Oxford and AstraZeneca's COVID-19 vaccine is considerably cheaper and easier to distribute than either Pfizer's or Moderna's. Here's why.

A half-dose of Oxford-AstraZeneca's COVID-19 vaccine initially could mean we have double the number doses available when it's approved by regulators. Siphiwe Sibeko/Pool via AP The University of Oxford and AstraZeneca's COVID-19 vaccine can be stored at normal fridge temperatures for at least six months. Unlike Pfizer and BioNTech's vaccine, it therefore doesn't require an ultra-cold storage and transport system, making it cheaper to distribute globally. The price per dose is also ...
Tags: Minnesota, US, Trends, Eu, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Welt am Sonntag, Andrew Pollard, Moderna, Siphiwe Sibeko, Stéphane Bancel


AstraZeneca and Oxford University's vaccine is effective at preventing COVID-19, trial results suggest. Here's everything we know so far.

Screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England, Thursday April 23, 2020 Oxford University Pool via AP On Monday, AstraZeneca and The University of Oxford released results for their large-scale trial, which showed their COVID-19 vaccine was 70% effective.  The Oxford vaccine is administered in two doses at least...
Tags: Europe, UK, England, US, Trends, Ap, Bbc, Britain, South Africa, Astrazeneca, Pfizer, University of Oxford, Oxford University, Agency, BBC Radio, Welt am Sonntag


The vaccine breakthroughs at Moderna and Pfizer are the latest examples of how immigrants have been driving billions in American innovation for decades

Noubar Afeyan, an immigrant from Lebanon, is the co-founder and chairman of Moderna, the company behind one of the most promising potential COVID019 vaccines. Flagship Pioneering Behind both Moderna and the Pfizer-BioNTech potential coronavirus vaccines are a group of incredible scientists, biotech CEOs, and venture capitalists funding the effort — many of whom are immigrants. Business Insider spoke with Moderna cofounder and chairman Noubar Afeyan, an immigrant himself, abou...
Tags: Spacex, Elon Musk, Greece, France, Germany, Russia, US, America, Trends, Tesla, Bloomberg, Turkey, Joe Biden, Mit, Cologne, Canada


Keeping coronavirus vaccines in a deep freeze one of California’s big challenges

Some are bigger than the fridge in your kitchen. Others are as small as the cooler you lug to the beach. They’re way colder than the Arctic, in extremely high demand and absolutely essential for getting the first wave of coronavirus vaccines — “the proverbial light at the end of this very long, dark tunnel,” as Gov. Gavin Newsom said — from the manufacturer into your body. Most of these specialized freezers cost $7,000 to $15,000 each, with the most imposing models topping out at $26,000 — and C...
Tags: News, California, Cdc, La, Sport, UPS, Public Health, Soccer, Arctic, Ohio, Vaccinations, Fda, Pfizer, Pasadena, Fedex, Gavin Newsom


Week in Review: Venture-backed loneliness

Hello everyone and welcome back to Week in Review! Natasha here, subbing in for Lucas while he’s out. This week, we’ll talk about loneliness raising money and how Zoom fatigue is fueling innovation. For everyone celebrating, happy holidays! Keep on the lookout next week for more festive content, including the launch of our annual TechCrunch Gift Guides. If you’re reading this on TechCrunch, you can sign up to get this in your inbox. The big story Over the last month, I spent time working out...
Tags: Apple, Google, Amazon, TC, Facebook, Twitter, Spacex, Mac, White House, Tech, Joe Biden, Intel, Nasa, Week in Review, Pfizer, MacBook Air


'The cavalry is on the way': Fauci says Americans should 'double down' on COVID-19 precautions as we reach the final stretch before the first vaccines

GRAEME JENNINGS/POOL/AFP via Getty Images This month, Moderna, BioNTech, and Pfizer all announced that their COVID-19 vaccine candidates had passed phase 3 testing.  Dr. Anthony Fauci, the nation's leading expert on COVID-19, said that Americans should take the breakthroughs as more reason to combat "COVID fatigue," at The New York Times DealBook conference Tuesday.  "The cavalry is on the way," Fauci said.  Visit Business Insider's homepage for more stories. Dr. Anthony Fauci, Director o...
Tags: Health, Science, News, Thanksgiving, Trends, New York Times, Italy, Fda, Pfizer, Anthony Fauci, New York Times Read, The Food and Drug Administration, Andrew Ross Sorkin, Fauci, Cambridge Massachusetts, National Institute of Allergy


Daily Crunch: Roblox is going public

Roblox opens its books, Snap makes an acquisition and Pfizer and BioNTech seek regulatory approval for their vaccine. This your Daily Crunch for November 20, 2020. The big story: Roblox is going public The child-friendly gaming company filed confidentially to go public in October, but it only published its S-1 document with financial information late yesterday. How do the numbers look? Well, Roblox is certainly growing quickly — total revenue increased 56% in 2019, and then another 68% in t...
Tags: Gaming, Europe, Finance, Tech, Pakistan, Pfizer, Hutchinson, Don, Danny Crichton, Orix, Roblox, Vonne Hutchinson, BioNtech, ReadySet, Daily Crunch, Carlos Gonzalez Cadenas


Pfizer just asked the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore receiving an injection. University of Maryland School of Medicine/AP Photo Pfizer and BioNTech requested that the US Food and Drug Administration review their coronavirus vaccine for emergency authorization, they announced Friday. The vaccine was found to be 95% effective at preventing COVID-19 in a late-stage trial. The FDA has said it might ...
Tags: News, US, Trends, Healthcare, Fda, Pfizer, Baltimore, Centers For Disease Control And Prevention, Reuters, US Food and Drug Administration, Baylor College of Medicine, University of Maryland School of Medicine, Moderna, Andrew Dunn, BioNtech, Albert Bourla


Pfizer and BioNTech apply for FDA emergency use authorization for coronavirus vaccine

Pfizer and BioNTech said they will submit to the US Food and Drug Administration today for an emergency use authorization for their coronavirus vaccine candidate.
Tags: Cnn, Fda, Pfizer, US Food and Drug Administration, BioNtech


Morgan Stanley predicts it will take 4 to 9 months to vaccinate the rest of the US after first responders and vulnerable people

Steve Parsons-WPA Pool/Getty Images Two COVID-19 vaccines, one made by Moderna, another by Pfizer and BioNTech, announced promising results from their Phase 3 trials this week.  Moderna announced that its vaccine was 94.5% effective on Monday, and Pfizer/BioNTech announced that their vaccine was 95% effective on Wednesday.  Assuming that one or both of the vaccines receive emergency approval from the FDA, first responders and vulnerable populations will receive vaccines through March, a n...
Tags: Science, News, US, Trends, Walgreens, Food And Drug Administration, Fda, Pfizer, Vaccine, Morgan Stanley, Cvs, CVS Health, Steve Parsons, Moderna, BioNtech, COVID-19


Pfizer Just Filed for Emergency Approval of Its Covid-19 Vaccine. What's Next?

On Friday morning, Pfizer and BioNTech announced that they would be seeking an emergency use authorization from the Food and Drug Administration today for their jointly developed covid-19 vaccine. If granted, that would make this vaccine likely the first to reach the public in the U.S., followed closely by Moderna’s…Read more...
Tags: Science, Cdc, Food And Drug Administration, Fda, Pfizer, Vaccines, Moderna, BioNtech, Coronavirus, Covid 19


Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval

Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer and BioNTech gained on Friday after saying they would submit their COVID-19 vaccine candidate to the FDA today for Emergency Use Authorization.The submission will potentially enable use of the vaccine in high-risk populations in the US by the middle to end of December, the companies said.The companies will be ready to distribute the vaccine within hours after authorization and expect to produce up to 50 million doses of its vaccine...
Tags: US, Trends, Markets, Tesla, Fda, Pfizer, Movers, Matthew Fox, Rob Arnott, BioNtech, Ashley Wilson, Mover, COVID-19, Covid-19 Vaccine, Pfizer BioNTech, Pfizer Stock


The latest on the march toward a successful coronavirus vaccine

Hollis Johnson/Business Insider Hello, It feels so dissonant — the good news about vaccines working at the same time as case counts are rising even higher, New York's shutting down its schools, and states and cities are making the tough decisions to lock back down in the hopes of mitigating even further spread of the virus. But that's indeed where we find ourselves in November 2020. How's everyone holding up? Has anyone restarted a hobby? My sourdough starter's back from hibernation as par...
Tags: Amazon, New York, Trends, Bill Gates, World Health Organization, Fda, Pfizer, Biden, Morgan Stanley, University Of Maryland, PillPack, Andrew, Blake, Shelby, Gilead, Vivek Murthy


Pfizer to submit vaccine to FDA today. High-risk people could get first shot in late December

Pfizer and BioNTech said they will submit to the US Food and Drug Administration today for an emergency use authorization for their coronavirus vaccine candidate.
Tags: News, Stories, Fda, Pfizer, US Food and Drug Administration, BioNtech


Pfizer is about to ask the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. University of Maryland School of Medicine/AP Photo Pfizer and BioNTech are about to request that the US Food and Drug Administration review their coronavirus vaccine for emergency authorization. The vaccine was 95% effective at preventing COVID-19 in a late-stage trial. The FDA has said it might take weeks to review the...
Tags: News, US, Trends, Healthcare, Fda, Pfizer, Baltimore, Centers For Disease Control And Prevention, Reuters, US Food and Drug Administration, Baylor College of Medicine, University of Maryland School of Medicine, Moderna, Andrew Dunn, BioNtech, Allana Akhtar


Pfizer and BioNTech to submit to FDA today for emergency authorization for their coronavirus vaccine

Pfizer and BioNTech said they will submit to the US Food and Drug Administration today for an emergency use authorization for their...
Tags: Fda, Pfizer, US Food and Drug Administration, BioNtech


Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today

Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative treatment with an application to be delivered today. Pfizer and BioNTech, who revealed earlier this week that their vaccine was 95% effective based on Phase 3 clinical trial data, are submitting for the emergency authorization in the U.S., as well as in Australia, Canada, Europe, Japan and the U....
Tags: Health, TC, Europe, Japan, Medicine, Australia, Tech, Medical Research, Canada, United States, United Kingdom, Vaccination, Fda, Pfizer, Biotech, Vaccines


Pfizer to seek FDA sign-off today for emergency COVID-19 vaccine usage

Pfizer and BioNTech said Friday that they intend to file a request for emergency use authorization in the U.S.
Tags: Finance, Article, Fda, Pfizer, FBN, Fbn/markets, FOXBusiness, Fox-business/health-care, Suzanne O'Halloran, Fox-business/politics/government-and-institutions, BioNtech, Fox-business/topic/coronavirus, E81d79c5-17d0-5b51-8e58-a4538c046af5


'Potentially catastrophic': Sen. Chris Murphy sounds the alarm on the Trump administration not briefing the Biden team on COVID-19 vaccine distribution

Chris Murphy. Zach Gibson/Getty Images The Trump administration told senators during a Thursday briefing that their vaccine team has not yet reached out to the Biden camp to begin coordination on vaccine rollout, Sen. Chris Murphy tweeted.  Murphy, who serves on the Senate's Health Education, Labor, and Pensions Committee, called the lack of outreach 62 days before Inauguration Day "potentially catastrophic." Two companies, Pfizer and Moderna, have recently reported promising results from ...
Tags: Politics, Science, Supreme Court, White House, US, Trends, Joe Biden, Connecticut, Commission, Food And Drug Administration, General Services Administration, Fda, Pfizer, Biden, Donald Trump, Clinton


2 stocks to buy on the Amazon Pharmacy news

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,Today in healthcare news: why Wall Street analyst thinks two of the healthcare stocks pummeled by the news of Amazon Pharmacy will explode, BI Deutschland's interview with BioNTech's CEO, and Moderna salaries revealed.   Customers can now purchase prescription medica...
Tags: Amazon, Wall Street, US, Trends, Healthcare, Pfizer, Vaccine, New Mexico, Pharmacy, Don, AmerisourceBergen, Moderna, BioNtech, Business Insider New York, BLAKE DODGE, GoodRx


Dow tumbles 345 points as fresh lockdown measures overshadow vaccine progress

Reuters / Lucas Jackson US stocks fell on Wednesday as new economic restrictions erased morning optimism around coronavirus vaccine news.New York City announced Wednesday afternoon that it will shut down public schools as virus infection rates spike.The vaccine candidate being developed by Pfizer and BioNTech was 95% effective at protecting against COVID-19 in patients in a late-stage trial, Pfizer said Wednesday. The firms plan to apply for emergency use authorization on Friday.Bitcoin su...
Tags: Energy, New York City, US, Trends, Markets, Bank Of America, Bitcoin, Food And Drug Administration, Treasury, Oil Price, Pfizer, Biden, Ba, Boeing, Gold Price, S&P 500


Moderna's coronavirus vaccine doesn't need to be as icy cold as Pfizer's, and that could make it easier to distribute

Oil markets surged in the hours after Pfizer announced positive results from its coronavirus vaccine study. Dado Ruvic/Reuters Moderna and Pfizer have both announced promising trial results this week, suggesting their coronavirus vaccines perform very well at preventing COVID-19 infections.  But Moderna's shots can be kept in the fridge for a month, while Pfizer's can only last five days that way.  Pfizer has developed special vaccine briefcases that can keep its shots frozen properly for ...
Tags: Science, News, US, Trends, Public Health, Fda, Pfizer, Vaccines, Reuters, US Food and Drug Administration FDA, Baltimore Maryland, University of Maryland School of Medicine, Adalja, Amesh Adalja, Pandemic, Moderna


BioNTech and Pfizer will seek emergency US authorization for vaccine on Friday, CEO says

German company BioNTech and its partner, drug giant Pfizer, will ask the US on Friday to allow emergency use of their Covid-19 vaccine candidate, CEO Ugur Sahin told CNN during an exclusive interview on Wednesday.
Tags: US, Cnn, Pfizer, BioNtech, Ugur Sahin


Live Updates: Pfizer coronavirus vaccine 95% effective, company says

Pfizer and BioNTech said its vaccine was found to be safe and 95% effective in phase 3 clinical trial, clearing the way for the...
Tags: Pfizer, BioNtech


Moderna and Pfizer's coronavirus vaccines are more than 94% effective. Here's how that compares to shots for flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer reported Wednesday that its coronavirus vaccine candidate was found to be 95% effective in preventing COVID-19 in clinical trials. Moderna's vaccine candidate was found to be 94.5% effective in trials. The chart below shows how the efficacy of those vaccine candidates compares to the effectiveness of...
Tags: Health, Science, News, Nbc, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Astrazeneca, Pfizer, Anthony Fauci, Johnson Johnson, Moderna, Andrew Dunn, BioNtech